Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Katsura Tottori
Observed names:
K Tottori,
K. TOTTORI,
K. Tottori
Institution:
Otsuka (Japan)
Observed institution:
Otsuka (Japan)
OpenAlex ID:
A5108406137
Aripiprazole, a Novel Antipsychotic, Is a High-Affinity Partial Agonist at Human Dopamine D2 Receptors
2002
·
Kevin D. Burris
, Thaddeus F. Molski
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
1,016
The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor
2002
·
Shaun Jordan
, Vuk Koprivica
, et al.
·
European Journal of Pharmacology
·
549
7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity.
1995
·
T Kikuchi
, K Tottori
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
302
Novel Antipsychotic Agents with Dopamine Autoreceptor Agonist Properties: Synthesis and Pharmacology of 7-[4-(4-Phenyl-1-piperazinyl)butoxy]-3,4-dihydro-2(1H)-quinolinone Derivatives
1998
·
Yasuo Oshiro
, Seiji Sato
, et al.
·
Journal of Medicinal Chemistry
·
150
In vivo effects of aripiprazole on cortical and striatal dopaminergic and serotonergic function
2003
·
Shaun Jordan
, Vuk Koprivica
, et al.
·
European Journal of Pharmacology
·
122
3,4-Dihydro-2(1 H )-quinolinone as a Novel Antidepressant Drug: Synthesis and Pharmacology of 1-[3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl]-3,4- dihydro-5-methoxy-2(1 H )-quinolinone and Its Derivatives
2000
·
Yasuo Oshiro
, Yoji Sakurai
, et al.
·
Journal of Medicinal Chemistry
·
100
Aripiprazole's low intrinsic activities at human dopamine D2L and D2S receptors render it a unique antipsychotic
2005
·
Yoshihiro Tadori
, Takashi Miwa
, et al.
·
European Journal of Pharmacology
·
92
The novel antipsychotic aripiprazole is a partial agonist at short and long isoforms of D2 receptors linked to the regulation of adenylyl cyclase activity and prolactin release
2004
·
Koutoku Aihara
, Jun Shimada
, et al.
·
Brain Research
·
67
Antidepressant-like responses to the combined sigma and 5-HT1A receptor agonist OPC-14523
2001
·
K Tottori
, T Miwa
, et al.
·
Neuropharmacology
·
48
Diminished catalepsy and dopamine metabolism distinguish aripiprazole from haloperidol or risperidone
2003
·
Satoru Nakai
, Tsuyoshi Hirose
, et al.
·
European Journal of Pharmacology
·
47
The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor
2001
·
S. Jordan
, V. Koprivica
, et al.
·
European Neuropsychopharmacology
·
41
Aripiprazole: A dopamine-serotonin system stabilizer
2002
·
A. Byars
, K. Burris
, et al.
·
European Neuropsychopharmacology
·
38
Attenuated stress-induced catecholamine release in mice lacking the vasopressin V1b receptor
2006
·
Shuji Itoh
, Sakiko Yamada
, et al.
·
American Journal of Physiology-Endocrinology and Metabolism
·
33
Attenuation of Scopolamine-Induced and Age-Associated Memory Impairments by the Sigma and 5-Hydroxytryptamine1A Receptor Agonist OPC-14523 (1-{3-[4-(3-chlorophenyl)-1-piperazinyl]propyl}-5-methoxy-3,4-dihydro-2[1 H]-quinolinone monomethanesulfonate)
2002
·
Katsura Tottori
, Masami Nakai
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
27
Aripiprazole: A dopamine-serotonin system stabilizer
2003
·
N. Kurahashi
, R. McQuade
, et al.
·
Schizophrenia Research
·
25
In vitro profile of the antidepressant candidate OPC-14523 at rat and human 5-HT1A receptors
2005
·
Shaun Jordan
, Ruoyan Chen
, et al.
·
European Journal of Pharmacology
·
8
Antidepressant effect of OPC-14823 in the forced swimming test in mice
1997
·
Katsura Tottori
, Tetauro Kikuchi
, et al.
·
The Japanese Journal of Pharmacology
·
5
PDF
ChemInform Abstract: Novel Cerebroprotective Agents with Central Nervous System Stimulating Activity. Part 2. Synthesis and Pharmacology of the 1‐(Acylamino)‐7‐ hydroxyindan Derivatives.
1991
·
Y. OSHIRO
, Y. SAKURAI
, et al.
·
ChemInform
·
3
The attenuating effect of carteolol hydrochloride, a β-adrenoceptor antagonist, on neuroleptic-induced catalepsy in rats
1997
·
T. Kikuchi
, Y. Uwahodo
, et al.
·
Psychopharmacology
·
2
7-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl] butyloxy}-3,4-dihydro-2(1H)-quinolinone (OPC-14597): A new antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity.
1994
·
Tetsuro Kikuchi
, Katsura Tottori
, et al.
·
The Japanese Journal of Pharmacology
·
2
PDF
ChemInform Abstract: Novel Antipsychotic Agents with Dopamine Autoreceptor Agonist Properties: Synthesis and Pharmacology of 7‐[4‐(4‐Phenyl‐1‐piperazinyl)butoxy]‐3,4‐dihydro‐2(1H)‐quinolinone Derivatives.
1998
·
Y. OSHIRO
, S. SATO
, et al.
·
ChemInform
·
1
Aripiprazole: a partial agonist at D2 receptors in rat pituitary cells
2005
·
Tsuyoshi Hirose
, Yasuhiko Inoue
, et al.
·
International Clinical Psychopharmacology
ChemInform Abstract: 3,4‐Dihydro‐2(1H)‐quinolinone as a Novel Antidepressant Drug: Synthesis and Pharmacology of 1‐[3‐[4‐(3‐Chlorophenyl)‐1‐piperazinyl]propyl] ‐3,4‐dihydro‐5‐methoxy‐2(1H)‐quinolinone and Its Derivatives.
2000
·
Yasuo Oshiro
, Yoji Sakurai
, et al.
·
ChemInform
Influence of aripiprazole (OPC-14597) on the induction of catalepsy and brain dopamine metabolism after chronic treatment: a comparison with haloperidol or risperidone
2000
·
Tsnvoshi Hirose
, Satoru Nakai
, et al.
·
The Japanese Journal of Pharmacology
PDF
OPC-14523: Receptor binding characterization studies on a novel antidepressant agent
1998
·
O.M. Adeyemo
, N.J Browder
, et al.
·
Toxicology Letters
Show more works
View as search
Works count:
37
Citation count:
2,678
H-index:
15
I10-index:
15
Year
Topic
Type